Published in N Engl J Med on September 01, 2015
Heart Failure and Sleep-Disordered Breathing--The Plot Thickens. N Engl J Med (2015) 1.63
Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis. JAMA (2017) 1.40
Central Sleep-disordered Breathing Predicts Incident Atrial Fibrillation in Older Men. Am J Respir Crit Care Med (2016) 1.39
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 1.07
Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: "The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses". J Clin Sleep Med (2016) 1.01
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics. J Physiol (2016) 0.92
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.91
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.88
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.88
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.87
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.85
ASV in CHF Recommendations Too Restrictive. J Clin Sleep Med (2016) 0.81
Sleep disordered breathing at the extremes of age: the elderly. Breathe (Sheff) (2016) 0.80
A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag (2016) 0.80
Pathogenesis of central and complex sleep apnoea. Respirology (2016) 0.80
Phenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches. Sleep Med Rev (2016) 0.79
Adaptive Servo-ventilation and the Treatment of Central Sleep Apnea in Heart Failure. Let's Not Throw the Baby Out with the Bathwater. Am J Respir Crit Care Med (2016) 0.78
Sleep-disordered breathing and cardiovascular disease. Indian Heart J (2015) 0.78
Role of sleep-disordered breathing and sleep-wake disturbances for stroke and stroke recovery. Neurology (2016) 0.78
Obstructive Sleep Apnoea Modulates Airway Inflammation and Remodelling in Severe Asthma. PLoS One (2016) 0.77
Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies. Clin Res Cardiol (2016) 0.77
Impact of obstructive and central apneas on ventricular repolarisation: lessons learned from studies in man and pigs. Clin Res Cardiol (2016) 0.77
Potential Expanded Indications for Neprilysin Inhibitors. Curr Heart Fail Rep (2017) 0.76
Comparison of Sleep Disorders between Real and Simulated 3,450-m Altitude. Sleep (2016) 0.76
The Positive and Negative about Positive Airway Pressure Therapy. Am J Respir Crit Care Med (2016) 0.76
Heart failure and sleep disorders. Nat Rev Cardiol (2016) 0.76
Heart failure in 2015: Better results from prevention than from additional treatment. Nat Rev Cardiol (2016) 0.76
It Happened While You Were Sleeping. J Am Heart Assoc (2016) 0.75
Heart failure: Central sleep apnoea in HF-what can we learn from SERVE-HF? Nat Rev Cardiol (2015) 0.75
Sleep-Disordered Breathing-Do We Have to Change Gears in Heart Failure? Curr Heart Fail Rep (2016) 0.75
Clinical update sleep: year in review 2015-2016. J Thorac Dis (2016) 0.75
Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension. Respir Res (2015) 0.75
Optimization of pressure settings during adaptive servo-ventilation support using real-time heart rate variability assessment: initial case report. BMC Cardiovasc Disord (2017) 0.75
Diaphragm pacing and motor neurone disease: lessons for all? ERJ Open Res (2015) 0.75
A Narrative Review of How Sleep-Related Breathing Disorders and Cardiovascular Diseases Are Linked: An Update for Advanced Practice Registered Nurses. Clin Nurse Spec (2016) 0.75
Keep Calm and Debate On. J Clin Sleep Med (2016) 0.75
Noninvasive Positive Pressure Ventilation in Chronic Heart Failure. Can Respir J (2016) 0.75
Noninvasive ventilation improves cardiac function in patients with chronic heart failure. Oncotarget (2016) 0.75
Adaptive Servo-Ventilation and Central Apnea Associated with Systolic Heart Failure. J Clin Sleep Med (2016) 0.75
The year in cardiology 2015: heart failure. Eur Heart J (2016) 0.75
Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. J Am Coll Cardiol (2017) 0.75
Update in respiratory sleep disorders: Prologue to a modern review series. Respirology (2016) 0.75
Prognostic Importance of Novel Oxygen Desaturation Metrics in Patients With Heart Failure and Central Sleep Apnea. J Card Fail (2016) 0.75
Update on clinical trials in home mechanical ventilation. J Thorac Dis (2016) 0.75
The SERVE-HF Trial. Can Respir J (2015) 0.75
Adaptive Servo-Ventilation for Central Sleep Apnea in Heart Failure. N Engl J Med (2016) 0.75
Comorbidity "depression" in heart failure - Potential target of patient education and self-management. BMC Cardiovasc Disord (2017) 0.75
Interfacing pathophysiology of respiratory sleep disorders, cardiac dysfunction, and focal autonomic medullary brain ischemia. J Thorac Dis (2015) 0.75
Adaptive servoventilation versus oxygen therapy for sleep disordered breathing in patients with heart failure: a randomised trial. Open Heart (2016) 0.75
Association of Central Sleep Apnea with Impaired Heart Structure and Cardiovascular Hemodynamics in Patients with Chronic Heart Failure. Med Sci Monit (2016) 0.75
Complementary roles of gasotransmitters CO and H2S in sleep apnea. Proc Natl Acad Sci U S A (2017) 0.75
Raising awareness about sleep disorders. Lung India (2017) 0.75
Effect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol (2017) 0.75
Expert OpinionShould We Let Sleeping Dogs Lie? Controversies of Treating Central Sleep Apnoea in HFrEF Following the SERVE-HF Study. Card Fail Rev (2016) 0.75
Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction. Curr Hypertens Rep (2017) 0.75
Patients with Cheyne-Stokes respiration and heart failure: patient tolerance after three-month discontinuation of treatment with adaptive servo-ventilation. Heart Vessels (2017) 0.75
New Challenges for Sleep Apnea Research: Simple Diagnostic Tools, Biomarkers, New Treatments and Precision Medicine. Sleep Sci (2017) 0.75
Sleep duration and quality in heart failure patients. Sleep Breath (2017) 0.75
Biomarkers in Sleep Apnea and Heart Failure. Curr Heart Fail Rep (2017) 0.75
Sleep-disordered breathing in heart failure: facts and numbers. ESC Heart Fail (2017) 0.75
Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med (2005) 6.20
Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med (2001) 2.72
Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail (2006) 2.33
Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol (2007) 2.29
Cheyne-Stokes respiration: friend or foe? Thorax (2012) 2.11
Adaptive servo-ventilation therapy for patients with chronic heart failure in a confirmatory, multicenter, randomized, controlled study. Circ J (2015) 2.03
Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis (1992) 1.91
Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol (2008) 1.87
Effect of adaptive servo-ventilation on 1-year prognosis in heart failure patients. Circ J (2011) 1.68
Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation (2012) 1.57
Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur J Heart Fail (2013) 1.47
Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med (1997) 1.46
Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Fail (2008) 1.45
Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing. Sleep Med (2009) 1.40
Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest (2012) 1.32
Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart (2009) 1.30
Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure. Respiration (1999) 1.27
Cardiac performance in response to PEEP in patients with cardiac dysfunction. Crit Care Med (1982) 1.27
Haemodynamic effects of continuous positive airway pressure in humans with normal and impaired left ventricular function. Clin Sci (Lond) (1995) 1.22
Hemodynamic effects of noninvasive bilevel positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest (2000) 1.17
A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO trial. Health Technol Assess (2009) 1.13
Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis. Clin Res Cardiol (2014) 1.09
The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med (2005) 20.72
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79
Effect of altitude on leptin levels, does it go up or down? J Appl Physiol (1985) (2008) 6.68
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA (2007) 6.25
Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39
Defibrillator implantation early after myocardial infarction. N Engl J Med (2009) 5.25
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA (2007) 4.30
Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med (2005) 3.84
Association of atrial fibrillation and obstructive sleep apnea. Circulation (2004) 3.81
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology (2013) 3.70
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol (2012) 3.56
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J (2006) 3.55
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol (2005) 3.53
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation (2003) 3.49
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation (2012) 3.42
Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart (2012) 3.36
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA (2008) 3.31
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation (2004) 3.30
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12
The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07
Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension (2005) 3.07
Poor sleep quality is associated with late noninvasive ventilation failure in patients with acute hypercapnic respiratory failure. Crit Care Med (2010) 3.05
Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation (2003) 3.04
Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol (2007) 2.99
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Plasma homocysteine in obstructive sleep apnoea. Eur Heart J (2004) 2.85
Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health (2011) 2.83
Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One (2010) 2.80
Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation (2003) 2.77
Obstructive sleep apnea. Ann Intern Med (2005) 2.75
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J (2005) 2.74
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension (2011) 2.68
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Ann Fam Med (2008) 2.59
Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial. Lancet Neurol (2015) 2.51
Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid (2004) 2.50
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain (2012) 2.49
Acute heart failure syndromes: current state and framework for future research. Circulation (2005) 2.47
Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. J Clin Microbiol (2010) 2.47
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol (2008) 2.35
Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail (2006) 2.33
Comments on Point:Counterpoint: Hypobaric hypoxia induces/does not induce different responses from normobaric hypoxia. J Appl Physiol (1985) (2012) 2.32
Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. Am J Epidemiol (2006) 2.31
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke (2009) 2.30
Sleep-disordered breathing and cardiovascular disease. Circulation (2003) 2.30
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol (2011) 2.29
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail (2011) 2.28
Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation (2004) 2.21
Obstructive sleep apnea is associated with increased high-sensitivity cardiac troponin T levels. Chest (2012) 2.21
Acupuncture in patients with osteoarthritis of the knee or hip: a randomized, controlled trial with an additional nonrandomized arm. Arthritis Rheum (2006) 2.20
Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc (2004) 2.14
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J (2011) 2.14
Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach. Circ Arrhythm Electrophysiol (2008) 2.13
The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res (2012) 2.11
History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure. Hypertension (2008) 2.09
Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial. Am J Respir Crit Care Med (2013) 2.07
Implications of geographical variation on clinical outcomes of cardiovascular trials. Am Heart J (2012) 2.06
Comparison of sleep quality with mechanical versus spontaneous ventilation during weaning of critically III tracheostomized patients. Crit Care Med (2013) 2.04
The European Respiratory Society plans its future: the 2013-2018 strategic plan. Eur Respir J (2014) 2.02
Effects of experimental sleep restriction on caloric intake and activity energy expenditure. Chest (2013) 2.02
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J (2007) 2.01
Leptin deficiency promotes central sleep apnea in patients with heart failure. Chest (2014) 1.99
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol (2008) 1.97
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol (2007) 1.92
Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother (2007) 1.91
Sleep quality in mechanically ventilated patients: comparison of three ventilatory modes. Crit Care Med (2008) 1.91
Sleep and cardiovascular disease. Curr Probl Cardiol (2005) 1.91
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol (2011) 1.89
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J (2011) 1.88
Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes (2011) 1.88
Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol (2008) 1.87
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol (2012) 1.87
Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.86